A novel thiadiazol-piperiimne substituted compound for plasmodium related diseases

PK144811BActive Publication Date: 2026-10-22NOVARTIS AG
0 Cites 0 Cited by

Patent Information

Application Number
PK202000717
Authority / Receiving Office
PK · PK
Patent Type
Patents
Current Assignee / Owner
Filing Date
2020-10-21
Publication Date
2026-10-22
Patent Text Reader

Abstract

The present invention provides a compound of formula (Ic); wherein: Z is N; Y1 is C(OH)CH2NH2; R1 is C1-4alkyl; R2a is C14alkyl; R2b is hydrogen and R3b, R3c , R3d, and R3e is each independently selected from hydrogen, C1-4alkyl, amino, -X1 - R3a ,NH-X1 -R3a, hydroxy-substituted-C1-4alkyl, C1-4alkoxy-substitutedC1-4alkyl, hydroxy, oxo, halo, -X1 -CO2H, -X1 -CO2NH2, -X1 -SO2C1-4 alkyl, -X1 -SO2N(C1-4alkyl)2, and -X1 -C3-6-cycloalkyl. It relates to the compound considered to be useful to treat or prevent plasmodium related diseases, for example malaria.
Need to check novelty before this filing date? Find Prior Art